Allied Market Research

Cephalosporin Market Expected to Reach $16.87 Billion by 2027—Allied Market Research


Report Code : A03170

quote introduction of combination drugs such as multiple antibacterials or antibacterials combined with an inhibitor drives the cephalosporin market growth. Use of combination drugs is expected to decrease the chances of evolution of antibiotic-resistant bacterial strains, which is expected to fuel growth of the market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, "Cephalosporin Market by Generation, Type, Route of Drug Administration, and Application: Opportunity Analysis and Industry Forecast, 2019–2027," the global cephalosporin market size was valued at $13.69 billion in 2019, and is estimated to reach $16.87 billion by 2027, growing at a CAGR of 2.6% from 2019 to 2027. The third-generation cephalosporin segment held more than 32% of the total cephalosporin market share in 2019. 

Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. The major factors contributing to the growth of the cephalosporin market include increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the market growth. However, side effects associated with cephalosporin and development of drug-resistant bacterial strains restrain the cephalosporin market growth.

Economies across the world are suffering from the impact of COVID-19 and many industries are experiencing losses. However, pharmaceutical companies have a center stage in the COVID-19 fight and are responding to rapid challenges arising from disturbances in supply chains and need to change business processes. If this pandemic lasts for a medium or long span of time, it may impact supply of active material and ingredients (mainly from China) as well as import and export of pharmaceuticals. However, the virus damages cells so badly that it becomes easier for certain bacteria to cause secondary infections, for instance, pneumonia in influenza patients, which can be treated with antibiotics and in such cases health care providers recommend cephalosporin as well as combination therapies of antibiotics. Hence, the impact of COVID-19 on cephalosporin industry is expected to be moderate.

Increase in incidence of population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhoea drives the market growth. In addition, increase in R&D activities to develop highly efficient & safe drugs and upsurge in use of combination therapies further boost the growth of the market. However, side effects associated with cephalosporin and evolution of antibiotic-resistant bacterial strains are expected to hamper the market growth. On the contrary, lucrative opportunities in the emerging economies are expected to propel the market growth in the future.

Based on application, the market is segmented into respiratory tract infection, skin infection, ear infection, urinary tract infection, sexually transmitted infection, and others. The respiratory tract infection segment generated the highest revenue in 2019 and is anticipated to maintain its dominance throughout the forecast period, as cephalosporin are used for treatment of both upper & lower respiratory tract infection and lower respiratory infections are the leading infectious causes of death globally. Hence, oral cephalosporin is used in the treatment of lower and upper respiratory tract infections widely. However, the sexually transmitted infection is expected to register highest CAGR during the forecast period, due to the rising rate of sexually transmitted infections globally and some second-generation cephalosporin and most of the third-generation cephalosporin are effective in the treatment.

Based on generation, the market is classified into first-generation cephalosporin, second-generation cephalosporin, third-generation cephalosporin, fourth-generation cephalosporin, and fifth-generation cephalosporin. The third-generation cephalosporin segment generated the highest revenue in 2019 and is anticipated to maintain its dominance throughout the forecast period, as these have a broader spectrum of activity and these are used for the treatment of Gram-negative bacillary meningitis, serious infections of enterobacteriaceae, otitis media, and others. However, the fifth-generation cephalosporin is expected to register highest CAGR of 3.9% during the forecast period.

Based on region, the antibiotics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific dominated the market in 2019, accounting for the highest share, and is anticipated to maintain cephalosporin market trends throughout the forecast period. This is attributed to increased consumption of cephalosporin, its easy availability, and rise in sale of over-the-counter drugs, and increase in bacterial infection in the region.

Key Findings Of The Study 

  • Generic cephalosporin segment is expected to register the highest CAGR of 3.1% during the analysis period.
  • Based on route of administration, the intravenous cephalosporin segment accounted for the largest share in 2019 and is expected to maintain its dominance during the forecast period.
  • India and China collectively contributed for more than 40% share of the Asia-Pacific cephalosporin market in 2019.
  • U.S. was the major shareholder that accounted for more than 90% of the North America cephalosporin market in 2019.

The report provides a comprehensive analysis of the key players operating in the global cephalosporin industry, Allergan Plc., Bristol-Myers Squibb Company, F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Lupin Limited (Lupin Pharmaceuticals, Inc.), Merck & Co. Inc., Novartis International AG, Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. The other players in the value chain include Eli Lilly and Company, Bayer HealthCare, Sun Pharmaceutical, Shionogi, and others.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975



For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Cephalosporin Market by Generation (First-generation, Second-generation, Third-Generation, Fourth-Generation, and Fifth-Generation), Type (Branded and Generic), Route of Drug Administration (Intravenous and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection): Global Opportunity Analysis and Industry Forecast, 2019–2027 quote

View Report
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 3,515 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.


Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Published Date Jan 2021

Surgical Equipment Market

Download Sample

Published Date Nov 2020

Medical Implant Market

Download Sample

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Cephalosporin Market"
Purchase Enquiry